Longevity Escape Velocity Foundation

— conducting and inspiring research to comprehensively cure and prevent human age-related disease.

“We are humanitarians first and foremost.”

— Dr. Aubrey de Grey

Projects

Robust Mouse Rejuvenation

Our flagship mouse longevity study will identify synergies between known rejuvenation therapies

Transplants On-Demand

We’re funding Keinice Bio’s novel cryopreservation technology to scale tissue and organ banking

Outreach & Events

Leadership

President & Chief Science Officer

Visionary biomedical gerontologist

Dr. Aubrey de Grey

Melissa King

Board Chair

Founding Executive Director, California Institute for Regenerative Medicine

David Wood

Executive Director

Veteran technology executive & futurist

News & Updates

LEV Foundation and Longevity Events Ltd. hosted the global longevity and rejuvenation community in Dublin on August 17-20.

With a roster of speakers including George Church, Brian Kennedy, Steve Horvath, David Sinclair and many more, it’s no exaggeration to state that the Summit was the most important longevity event to take place in the EU this year.

Attendees networked with leading figures around the world, built relationships with the longevity science industry and community, and learned about the latest emerging research.

Special thanks are due to Maxwell Biosciences, Ichor Life Sciences, and the other sponsors who helped make the event such a success.

Stay tuned for updates on everything we discovered!

The 2024 Summit will take place on June 13-16. Discounted Early Bird Tickets are already available - book your place now!

Robust Mouse Rejuvenation

Featured
December 30th, 2024

Just four mice have made it to 2025 (yeah, I'm 55 hours optimistic there...), all of them male, and once they die I will launch into the next phase of updates, which will consist of lots of statistical analyses of the survival curves, followed by various reports on our healthspan data. For now, though, I will continue the habit of highlighting some of the qualitative impressions that the survival curves are telling us.

Read More →
October 6th, 2024

The milestone we have hit this time is that all 20 groups (10 male and 10 female) have now reached their last "cull point", i.e. the point where only eight mice of the original 50 are alive and we sacrifice two of them to store various tissues, as well as doing a lot of the non-invasive measurements on the others...

Read More →
August 17th, 2024

We're getting fairly near to the end of the study - but how near, we certainly can't yet say. Six of the 20 treatment groups, two male and four female, are now extinct, but the all-treatment groups of both sexes are still at 25% survival at over 35 months of age, which gives hope that the longest-lived mouse in the entire study will turn out to be fairly impressive...

Read More →